[1]
|
郎景和. 对子宫内膜异位症认识的历史、现状与发展[J]. 中国实用妇科与产科杂志, 2020, 36(3): 193-196.
|
[2]
|
DiVasta, A.D., Vitonis, A.F., Laufer, M.R. and Missmer, S.A. (2018) Spectrum of Symptoms in Women Diagnosed with Endometriosis during Adolescence vs Adulthood. American Journal of Obstetrics & Gynecology, 218, e1-324.
https://doi.org/10.1016/j.ajog.2017.12.007
|
[3]
|
郎景和. 子宫内膜异位症的研究与设想[J]. 中华妇产科杂志, 2003, 38(8): 478-480.
https://doi.org/10.3760/j.issn:0529-567X.2003.08.018
|
[4]
|
Krawczyk, N., Banys-Paluchowski, M., Schmidt, D., Ulrich, U. and Fehm, T. (2016) Endometriosis-Associated Malignancy. Geburtshilfe und Frauenheilkunde, 76, 176-181. https://doi.org/10.1055/s-0035-1558239
|
[5]
|
Melin, A., Sparén, P., Persson, I. and Bergqvist, A. (2006) Endometriosis and the Risk of Cancer with Special Emphasis on Ovarian Cancer. Human Reproduction, 21, 1237-1242. https://doi.org/10.1093/humrep/dei462
|
[6]
|
Melin, A., Sparén, P. and Bergqvist, A. (2007) The Risk of Cancer and the Role of Parity among Women with Endometriosis. Human Reproduction, 22, 3021-3026. https://doi.org/10.1093/humrep/dem209
|
[7]
|
Brinton, L.A., Gridley, G., Persson, I., Baron, J. and Bergqvist, A. (1997) Cancer Risk after a Hospital Discharge Diagnosis of Endometriosis. American Journal of Obstetrics & Gyne-cology, 176, 572-579.
https://doi.org/10.1016/S0002-9378(97)70550-7
|
[8]
|
Brinton, L.A., Sakoda, L.C., Sherman, M.E., et al. (2005) Relationship of Benign Gynecologic Diseases to Subsequent Risk of Ovarian and Uterine Tumors. Cancer Epidemiology, Biomarkers & Prevention, 14, 2929-2935.
https://doi.org/10.1158/1055-9965.EPI-05-0394
|
[9]
|
Kobayashi, H. (2016) Potential Scenarios Leading to Ovarian Cancer Arising from Endometriosis. Redox Report, 21, 119-126. https://doi.org/10.1016/S0002-9378(15)30003-X
|
[10]
|
Bounous, V.E., Ferrero, A., Fuso, L., et al. (2016) Endo-metriosis-Associated Ovarian Cancer: A Distinct Clinical Entity? Anticancer Research, 36, 3445-3449.
|
[11]
|
Sampson, J.A. (1927) Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation. The American Journal of Pathology, 3, 93-110.
|
[12]
|
Scott, R.B. (1953) Malignant Changes in Endometriosis. Obstetrics & Gynecology, 2, 283-289.
|
[13]
|
Sampson, J.A. (1927) Peritoneal Endometriosis due to the Menstrual Dissemination of Endometrial Tissue into the Peritoneal Cavity. American Journal of Obstetrics & Gynecology, 14, 422-469.
https://doi.org/10.1016/S0002-9378(15)30003-X
|
[14]
|
Kvaskoff, M., Mahamat-Saleh, Y., Farland, L.V., et al. (2021) Endometriosis and Cancer: A Systematic Review and Meta-Analysis. Human Reproduction Update, 27, 393-420. https://doi.org/10.1093/humupd/dmaa045
|
[15]
|
Yachida, N., Yoshihara, K., Yamaguchi, M., Suda, K., Tamura, R. and Enomoto, T. (2021) How Does Endometriosis Lead to Ovarian Cancer? The Molecular Mechanism of Endometriosis-Associated Ovarian Cancer Development. Cancers, 13, Article No. 1439. https://doi.org/10.3390/cancers13061439
|
[16]
|
王姝, 郎景和. 子宫内膜异位症相关性卵巢癌的研究现状及展望[J]. 中国实用妇科与产科杂志, 2017, 33(4): 360-364.
|
[17]
|
Varga, J., Reviczká, A., Háková, H., Švajdler, P., Rabajdová, M. and Ostró, A. (2022) Predictive Factors of Endometriosis Progression into Ovarian Cancer. Journal of Ovarian Research, 15, Article No. 5.
https://doi.org/10.1186/s13048-021-00940-8
|
[18]
|
孙婷婷, 王姝, 刘玉婷, 郎景和. 子宫内膜异位症相关性卵巢透明细胞癌与子宫内膜样癌的临床及预后特点[J]. 生殖医学杂志, 2019, 28(4): 321-330.
|
[19]
|
赵飞, 于新平, 赵涵, 宋冰冰, 吕广伟, 张世红, 王黎明. GLI1及Shh在卵巢型子宫内膜异位症恶变过程中的表达及其意义[J]. 中华妇产科杂志, 2022, 57(2): 125-132.
|
[20]
|
Li, Q., Sun, Y., Zhang, X., et al. (2019) Endometriosis-Associated Ovarian Cancer Is a Single Entity with Distinct Clinicopathological Characteristics. Cancer Biology & Therapy, 20, 1029-1034.
https://doi.org/10.1080/15384047.2019.1595278
|
[21]
|
Davis, M.,Rauh-Hain, J.A., Andrade, C., et al. (2014) Comparison of Clinical Outcomes of Patients with Clear Cell and Endometrioid Ovarian Cancer Associated with En-dometriosis to Papillary Serous Carcinoma of the Ovary. Gynecologic Oncology, 132, 760-766. https://doi.org/10.1016/j.ygyno.2014.01.012
|
[22]
|
Scarfone, G., Bergamini, A., Noli, S., et al. (2014) Characteris-tics of Clear Cell Ovarian Cancer Arising from Endometriosis: A Two Center Cohort Study. Gynecologic Oncology, 133, 480-484. https://doi.org/10.1016/j.ajog.2012.12.004
|
[23]
|
Wang, S., Qiu, L., Lang, J.H., et al. (2013) Clinical Analysis of Ovarian Epithelial Carcinoma with Coexisting Pelvic Endometriosis. American Journal of Obstetrics & Gynecology, 208, 413.E1-413.E5.
https://doi.org/10.1016/j.ajog.2012.12.004
|
[24]
|
Ye, S., Yang, J., You, Y., et al. (2014) Comparative Study of Ovarian Clear Cell Carcinoma with and without Endometriosis in People’s Republic of China. Fertility and Sterility, 102, 1656-1662.
https://doi.org/10.1016/j.fertnstert.2014.08.008
|
[25]
|
Zhang, X., Li, M., Tang, Z., Li, X. and Song, T. (2021) Dif-ferentiation between Endometriosis-Associated Ovarian Cancers and Non- Endometriosis-Associated Ovarian Cancers Based on Magnetic Resonance Imaging. The British Journal of Radiology, 94, Article ID: 20201441. https://doi.org/10.1259/bjr.20201441
|
[26]
|
Moss, L.D. and Runals, A.L. (1948) Carcinoma of the Ovary Arising in an Endometrial Cyst. New York State Journal of Medicine, 48, 401-406.
|
[27]
|
Huang, X., Wu, B., Li, J., et al. (2019) Anti-Tumour Effects of Red Blood Cell Membrane-Camouflaged Black Phosphorous Quantum Dots Combined with Chemotherapy and Anti-Inflammatory Therapy. Artificial Cells, Nanomedicine, and Biotechnology, 47, 968-979. https://doi.org/10.1080/21691401.2019.1584110
|
[28]
|
Furuya, M., Tanaka, R., Miyagi, E., et al. (2012) Impaired CXCL4 Expression in Tumor-Associated Macrophages (TAMs) of Ovarian Cancers Arising in Endometriosis. Cancer Biology & Therapy, 13, 671-680.
https://doi.org/10.4161/cbt.20084
|
[29]
|
Riccio, L.D.G.C., Santulli, P., Marcellin, L., et al. (2018) Immunology of Endometriosis. Best Practice & Research Clinical Obstetrics & Gynaecology, 50, 39-49. https://doi.org/10.1016/j.bpobgyn.2018.01.010
|
[30]
|
Su, K.M., Wang, P.H., Yu, M.H., Chang, C.-M. and Chang, C.-C. (2020) The Recent Progress and Therapy in Endometriosis-Associated Ovarian Cancer. Journal of the Chinese Medical Association, 83, 227-232.
https://doi.org/10.1039/C7NR04990K
|
[31]
|
Wang, Z., Liang, C., Shi, F., et al. (2017) Cancer Vaccines Using Supramolecular Hydrogels of NSAID-Modified Peptides as Adjuvants Abolish Tumorigenesis. Nanoscale, 9, 14058-14064. https://doi.org/10.1039/C7NR04990K
|
[32]
|
魏巧红, 武晓红. 子宫内膜异位症相关性卵巢癌的研究进展[J]. 肿瘤研究与临床, 2022, 34(3): 227-230.
|
[33]
|
Guo, S.W. (2020) Cancer-Associated Mutations in En-dometriosis: Shedding Light on the Pathogenesis and Pathophysiology. Human Reproduction Update, 26, 423-449. https://doi.org/10.1093/humupd/dmz047
|
[34]
|
Bulun, S.E., Wan, Y. and Matei, D. (2019) Epithelial Mutations in Endometriosis: Link to Ovarian Cancer. Endocrinology, 160, 626-638. https://doi.org/10.1155/2015/848595
|
[35]
|
Iwabuchi, T., Yoshimoto, C., Shigetomi, H. and Kobayashi, H. (2015) Oxidative Stress and Antioxidant Defense in Endometriosis and Its Malignant Transformation. Oxidative Medicine and Cellular Longevity, 2015, Article ID: 848595.
https://doi.org/10.1155/2015/848595
|
[36]
|
Amano, T., Murakami, A., Murakami, T. and Chano, T. (2021) Anti-oxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma. Antioxidants, 10, Article No. 187. https://doi.org/10.3892/or.2018.6946
|
[37]
|
Kobayashi, H., Yamada, Y., Kawahara, N., Ogawa, K. and Yoshimoto, C. (2019) Integrating Modern Approaches to Pathogenetic Concepts of Malignant Transformation of Endometriosis. Oncology Reports, 41, 1729-1738.
https://doi.org/10.3892/or.2018.6946
|
[38]
|
Xie, H., Chen, P., Huang, H.W., Liu, L.P. and Zhao, F. (2017) Reactive Oxygen Species Down-Regulate ARID1A Expression via Its Promoter Methylation during the Pathogenesis of Endometriosis. European Review for Medical and Pharmacological Sciences, 21, 4509-4515.
|
[39]
|
Stewart, C.J., Leung, Y., Walsh, M.D., et al. (2012) KRAS Mutations in Ovarian Low-Grade Endometrioid Adenocarcinoma: Association with Concurrent Endometriosis. Human Pathology, 43, 1177-1183.
https://doi.org/10.1016/j.ejogrb.2018.09.026
|
[40]
|
Bastu, E., Onder, S., Demiral, I., et al. (2018) Distinguishing the Progression of an Endometrioma: Benign or Malignant? European Journal of Obstetrics & Gynecology and Re-productive Biology, 230, 79-84.
https://doi.org/10.1016/j.ejogrb.2018.09.026
|
[41]
|
Sansal, I. and Sellers, W.R. (2004) The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway. Journal of Clinical Oncology, 22, 2954-2963. https://doi.org/10.1200/JCO.2004.02.141
|
[42]
|
Dinulescu, D.M., Ince, T.A., Quade, B.J., Shafer, S.A., Crowley, D. and Jacks, T. (2005) Role of K-ras and Pten in the Development of Mouse Models of Endometriosis and Endometrioid Ovarian Cancer. Nature Medicine, 11, 63-70.
https://doi.org/10.1038/nm1173
|
[43]
|
Ma, X., Hui, Y., Lin, L., Wu, Y., Zhang, X. and Qin, X. (2016) Possible Relevance of Tumor-Related Genes Mutation to Malignant Transformation of Endometriosis. European Journal of Gynaecological Oncology, 37, 89-94.
|
[44]
|
叶云, 黄紫艳, 陈颖. 雌激素受体PTEN及环氧合酶-2在子宫内膜异位症相关性卵巢癌患者中的表达[J]. 中国妇幼保健, 2021, 36(5): 1168-1171. https://doi.org/10.19829/j.zgfybj.issn.1001-4411.2021.05.062
|
[45]
|
Lv, J., Zhu, Q., Jia, X., Yu, N. and Li, Q. (2016) In Vitro and in Vivo Effects of Tumor Suppressor Gene PTEN on Endometriosis: An Experimental Study. Medical Science Monitor, 22, 3727-3736. https://doi.org/10.12659/MSM.901091
|
[46]
|
Trizzino, M., Barbieri, E., Petracovici, A., et al. (2018) The Tumor Suppressor ARID1A Controls Global Transcription via Pausing of RNA Polymerase Ⅱ. Cell Reports, 23, 3933-3945. https://doi.org/10.1126/science.1196333
|
[47]
|
Jones, S., Wang, T.L., Shih, I.-M., et al. (2010) Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma. Science, 330, 228-231. https://doi.org/10.1126/science.1196333
|
[48]
|
Kurman, R.J. and Shih, I.-M. (2011) Molecular Pathogenesis and Extraovarian Origin of Epithelial Ovarian Cancer—Shifting the Paradigm. Human Pathology, 42, 918-931. https://doi.org/10.1016/j.humpath.2011.03.003
|
[49]
|
Wiegand, K.C., Hennessy, B.T., Leung, S., et al. (2014) A Functional Proteogenomic Analysis of Endometrioid and Clear Cell Carcinomas Using Reverse Phase Protein Array and Mutation Analysis: Protein Expression Is Histotype-Specific and Loss of ARID1A/BAF250a Is Associated with AKT Phosphorylation. BMC Cancer, 14, Article No. 120. https://doi.org/10.1186/1471-2407-14-120
|
[50]
|
Yamamoto, S., Tsuda, H., Takano, M., Tamai, S. and Matsubara, O. (2012) Loss of ARID1A Protein Expression Occurs as an Early Event in Ovarian Clear Cell Carcinoma Development and Frequently Coexists with PIK3CA Mutations. Modern Pathology, 25, 615-624. https://doi.org/10.1038/modpathol.2011.189
|
[51]
|
Suda, K., Cruz Diaz, L.A., Yoshihara, K., et al. (2020) Clonal Lineage from Normal Endometrium to Ovarian Clear Cell Carcinoma through Ovarian Endometriosis. Cancer Science, 111, 3000-3009. https://doi.org/10.1111/cas.14507
|
[52]
|
Madanes, D., Bilotas, M.A., Bastón, J.I., et al. (2020) PI3K/AKT Pathway Is Altered in the Endometriosis Patient’s Endometrium and Presents Differences According to Severity Stage. Gynecological Endocrinology, 36, 436-440.
https://doi.org/10.1055/s-0036-1597120
|
[53]
|
Wilbur, M.A., Shih, I.M., Segars, J.H. and Fader, A.N. (2017) Can-cer Implications for Patients with Endometriosis. Seminars in Reproductive Medicine, 35, 110-116. https://doi.org/10.1055/s-0036-1597120
|
[54]
|
魏娜, 韩萍. P53、ki-67的表达与上皮性卵巢癌预后相关性分析[J]. 华北理工大学学报(医学版), 2019, 21(6): 454-459. https://doi.org/10.19539/j.cnki.2095-2694.2019.06.007
|
[55]
|
王丽宏, 叶霞, 吕家峰. 卵巢子宫内膜异位症恶性变过程中p53蛋白的表达变化[J]. 基层医学论坛, 2015, 19(33): 4614-4615, 4616.
|
[56]
|
Akahane, T., Sekizawa, A., Purwosunu, Y., Nagatsuka, M. and Okai, T. (2007) The Role of p53 Mutation in the Carcinomas Arising from En-dometriosis. International Journal of Gynecological Pathology, 26, 345-351.
https://doi.org/10.1097/pgp.0b013e31802b41a8
|
[57]
|
刘丽丹. 蛋白激酶CK2β及抑癌基因蛋白p53在卵巢癌组织中的表达[J]. 中国妇幼保健, 2017, 32(19): 4818-4821.
|
[58]
|
Wu, R.L., Ali, S., Bandyopadhyay, S., et al. (2015) Comparative Analysis of Differentially Expressed miRNAs and their Downstream mRNAs in Ovarian Cancer and its Associated Endometriosis. Journal of Cancer Science & Therapy, 7, 258-265.
|
[59]
|
Gaia-Oltean, A.I., Braicu, C., Gulei, D., et al. (2021) Ovarian Endometriosis, a Precursor of Ovarian Cancer: Histological Aspects, Gene Expression and microRNA Alterations (Review). Experimental and Therapeutic Medicine, 21, 243-243. https://doi.org/10.3892/etm.2021.9674
|
[60]
|
Pavone, M.E. and Lyttle, B.M. (2015) Endometriosis and Ovarian cancer: Links, Risks, and Challenges Faced. International Journal of Women’s Health, 7, 663-672. https://doi.org/10.2147/IJWH.S66824
|
[61]
|
Braicu, O.L., Budisan, L., Buiga, R., et al. (2017) miRNA Expression Profiling in Formalin-Fixed Paraffin-Embedded Endometriosis and Ovarian Cancer Samples. OncoTargets and Therapy, 10, 4225-4238.
https://doi.org/10.2147/OTT.S137107
|
[62]
|
Marí-Alexandre, J., Carcelén, A.P., Agababyan, C., et al. (2019) In-terplay between microRNAs and Oxidative Stress in Ovarian Conditions with a Focus on Ovarian Cancer and Endo-metriosis. International Journal of Molecular Sciences, 20, Article No. 5322. https://doi.org/10.3390/ijms20215322
|
[63]
|
杨永彬, 刘玲, 王炎秋, 杨懿霞, 万小平. 卵巢和卵巢肿瘤中Hedgehog信号通路的表达[J]. 上海交通大学学报(医学版), 2009, 29(4): 426-430.
|
[64]
|
朱奕晓, 王艳. Hedgehog信号通路与常见妇科恶性肿瘤的研究进展[J]. 医学综述, 2017, 23(12): 2364-2369.
|
[65]
|
Deb, B., Uddin, A. and Chakraborty, S. (2018) miRNAs and Ovarian Cancer: An Overview. Journal of Cellular Physiology, 233, 3846-3854. https://doi.org/10.1002/jcp.26095
|
[66]
|
Nguyen, V.H.L., Hough, R., Bernaudo, S. and Peng, C. (2019) Wnt/β-Catenin Signalling in Ovarian Cancer: Insights into Its Hyperactivation and Function in Tumorigenesis. Journal of Ovarian Research, 12, Article No. 122.
https://doi.org/10.1186/s13048-019-0596-z
|
[67]
|
李孝琼, 肖云峰, 吴妮莎, 徐黎明, 罗博, 周国俊, 冷政伟. 肿瘤干细胞及Wnt/β-catenin信号通路在结直肠癌肝转移中的作用[J]. 中华肝脏外科手术学电子杂志, 2019, 8(4): 377-378.
|
[68]
|
Adamson, G.D., Kennedy, S.H. and Hummelshoj, L. (2010) Creating Solutions in Endometriosis: Global Collaboration through the World Endometriosis Research Foundation. Journal of Endometriosis and Pelvic Pain Disorders, 2, 3-6.
https://doi.org/10.1177/228402651000200102
|
[69]
|
范晓杰, 王心然, 岳萌, 等. PD-L1在三阴性乳腺癌组织中表达及其与脉管生成的关系[J]. 中国肿瘤生物治疗杂志, 2019, 26(11): 1229-1234.
|
[70]
|
Goldsberry, W.N., Me-za-Perez, S., Londoño, A.I., Katre, A.A., Mott, B.T., Roane, B.M., Goel, N., Wall, J.A., Cooper, S.J., Norian, L.A., Randall, T.D., Birrer, M.J. and Arend, R.C. (2020) Inhibiting WNT Ligand Production for Improved Immune Recogni-tion in the Ovarian Tumor Microenvironment. Cancers, 12, Article No. 766.
https://doi.org/10.3390/cancers12030766
|
[71]
|
Stamos, J.L. and Weis, W.I. (2013) The β-Catenin Destruction Complex. Cold Spring Harbor Perspectives in Biology, 5, a007898. https://doi.org/10.1101/cshperspect.a007898
|
[72]
|
Fu, F., Deng, Q., Li, R., Wang, D., Yu, Q.X., Yang, X., Lei, T.Y., Han, J., Pan, M., Zhen, L., Li, J., Li, F.T., Zhang, Y.L., Li, D.Z. and Liao, C. (2020) AXIN2 Gene Silencing Re-duces Apoptosis through Regulating Mitochondria-Associated Apoptosis Signaling Pathway and Enhances Proliferation of ESCs by Modulating Wnt/β-Catenin Signaling Pathway. European Review for Medical and Pharmacological Sciences, 24, 418-427.
|
[73]
|
陶玲, 于春霞, 李霞, 周琦. β-连环蛋白、轴蛋白在卵巢上皮细胞癌组织中的表达及意义[J]. 中国妇幼保健, 2015, 30(15): 2356-2358.
|
[74]
|
李艳, 马玲, 张伊莉, 蒋涛, 毕国斌, 邵晨. β-catenin、Axin在卵巢上皮细胞癌组织中的表达及临床意义[J]. 现代中西医结合杂志, 2017, 26(26): 2871-2873, 2957.
|